0001567619-21-010897.txt : 20210521 0001567619-21-010897.hdr.sgml : 20210521 20210521160905 ACCESSION NUMBER: 0001567619-21-010897 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210521 DATE AS OF CHANGE: 20210521 EFFECTIVENESS DATE: 20210521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gennao Bio, Inc. CENTRAL INDEX KEY: 0001862102 IRS NUMBER: 852712100 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-400266 FILM NUMBER: 21949064 BUSINESS ADDRESS: STREET 1: 601 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-739-6400 MAIL ADDRESS: STREET 1: 601 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 D 1 primary_doc.xml X0708 D LIVE 0001862102 Gennao Bio, Inc. 601 Lexington Avenue NEW YORK NY NEW YORK 10022 212-739-6400 DELAWARE Delmab Bio, Inc. None Corporation true 2020 Stephen Squinto c/o Gennao Bio, Inc. 601 Lexington Avenue New York NY NEW YORK 10022 Executive Officer Director Promoter Dr. Squinto is the Executive Executive Officer, Chairman, President, Treasurer and Secretary of the Issuer. Chris Duke c/o Gennao Bio, Inc. 601 Lexington Avenue New York NY NEW YORK 10022 Executive Officer Mr. Duke is the Chief Operating Officer of the Issuer. Bruce Turner c/o Gennao Bio, Inc. 601 Lexington Avenue New York NY NEW YORK 10022 Director Chau Khuong c/o Gennao Bio, Inc. 601 Lexington Avenue New York NY NEW YORK 10022 Director Biotechnology Decline to Disclose 06b false 2021-05-06 false true true Series A Preferred Stock false 0 40000019 10000005 30000014 false 3 0 0 0 false Gennao Bio, Inc. /s/ Chris Duke Chris Duke Chief Operating Officer of the Issuer 2021-05-21